Search - tctmd.com

Displaying 521 - 540 of 670

Sort: Relevancy | Date

Presentation TCT 2017

Alcohol-Mediated Renal Denervation With a Higher-Dose: From the European Registry to Target BP 1

Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud

October 30, 2017

Presentation TCT 2017

Vessix RE-INFORCE Trial Update

Presenter: Michael Böhm, Thomas F. Luscher, Michael A. Weber

October 30, 2017

Presentation TCT 2017

Catheter-Based Ultrasound Renal Denervation: RADIANCE Trial Update

Presenter: Michael Böhm, Thomas F. Luscher, Laura Mauri

October 30, 2017

Presentation TCT 2017

KONAs WAVE IV Randomized Trial: Principal Results and Lessons Learned

Presenter: Michael Böhm, Thomas F. Luscher, Melvin D. Lobo

October 30, 2017

Presentation TCT 2017

First Results From the SPYRAL Hypertension Program (OFF-MED Study)

Presenter: Michael Böhm, Thomas F. Luscher

October 30, 2017

Presentation TCT 2017

Perspectives on Current Trials in Renal Denervation: Evolution of Design, Endpoints, and Objectives

Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud

October 30, 2017

Presentation TCT 2017

Potential Interventions for Hypertensive Patients With HFpEF

Presenter: Mark C. Bates, Bernard J. Gersh, William T. Abraham

October 30, 2017

Presentation TCT 2017

When Should Coronary Disease Be Suspected and Worked Up in Hypertension?

Presenter: Mark C. Bates, Bernard J. Gersh, Farrell O. Mendelsohn

October 30, 2017

Presentation TCT 2017

Why Are Hypertension and Coronary Artery Disease So Connected?

Presenter: Mark C. Bates, Bernard J. Gersh, Suzanne Oparil

October 30, 2017

Presentation TCT 2017

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Presenter: Mark C. Bates, Bernard J. Gersh, Michael R. Jaff

October 30, 2017

Presentation TCT 2017

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

What is the Optimal Therapy for Hypertension?

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

New U.S. Hypertension Guidelines and Treatment Targets

Presenter: Sidney C. Smith, Michael A. Weber, Sandra J Taler

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

Presentation TCT 2017

Valvular Heart Disease: Diagnosis and Treatment Options 2017

Presenter: Grzegorz L. Kaluza, Jose M. Wiley, Nicola Corvaja

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Opinion Fellow Talk

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Kimberly Atianzar, MD

October 11, 2017

News Daily News

Physical Activity of Any Ilk Cuts CVD, Deaths in Global Study: PURE

Shelley Wood

September 22, 2017

News Daily News

Patients in PCI Trials Vary Around the World, With Women Still Underrepresented

Michael O'Riordan

September 15, 2017

Advertisement

Alcohol-Mediated Renal Denervation With a Higher-Dose: From the European Registry to Target BP 1

Vessix RE-INFORCE Trial Update

Catheter-Based Ultrasound Renal Denervation: RADIANCE Trial Update

KONAs WAVE IV Randomized Trial: Principal Results and Lessons Learned

First Results From the SPYRAL Hypertension Program (OFF-MED Study)

Perspectives on Current Trials in Renal Denervation: Evolution of Design, Endpoints, and Objectives

Potential Interventions for Hypertensive Patients With HFpEF

When Should Coronary Disease Be Suspected and Worked Up in Hypertension?

Why Are Hypertension and Coronary Artery Disease So Connected?

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

What is the Optimal Therapy for Hypertension?

New U.S. Hypertension Guidelines and Treatment Targets

Off Script: Welcome to TCT 2017 in the Mile High City

Valvular Heart Disease: Diagnosis and Treatment Options 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Physical Activity of Any Ilk Cuts CVD, Deaths in Global Study: PURE

Patients in PCI Trials Vary Around the World, With Women Still Underrepresented

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content